Physician profile
Sharon Koubek
NPI 1518293430
$478.87
in general payments reported to CMS, 2019-2025
9 companies · $96.07 in 2025
The $96.07 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $194 · 2022: $24.01 · 2023: $62.46 · 2024: $102 · 2025: $96.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $260.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $145.11 | 2021 | |
| Cranial Technologies, INC | $75.73 | 2024-2025 | Doc Band |
| Pfizer INC. | $58.97 | 2021-2024 | |
| Glaxosmithkline, LLC. | $56.25 | 2021-2023 | Bexsero, Pediarix, Rotarix |
| Cumberland Pharmaceuticals, INC. | $44.43 | 2023-2025 | Kristalose |
| Sanofi-Aventis U.S. LLC | $38.67 | 2024-2025 | |
| Sanofi Pasteur INC. | $26.78 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $16.91 | 2024 | Flumist Quadrivalent |
| Merck Sharp & Dohme LLC | $16.02 | 2025 | Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Koubek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.